Chikungunya Vaccine, Live (Cvx 317) Dosage

Medically reviewed by Drugs.com. Last updated on Feb 18, 2024.

Usual Adult Dose for Chikungunya Fever

0.5 mL IM ONCE

Comments:

• This vaccine may not protect everyone against the chikungunya virus (CHIKV).
• Patients should take personal precautions to lower their risk of exposure to mosquito bites (e.g., use of adequate clothing, mosquito nets, repellants).

Use: For prevention of disease caused by CHIKV in patients at increased risk of exposure to CHIKV

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

• Patients with a history of severe allergic reaction (e.g., anaphylaxis) to the active component or any of the ingredients
• Patients who are immunodeficient/immunosuppressed due to disease/medical therapy (e.g., chemotherapy, congenital immunodeficiency, hematologic/solid tumors, long-term immunosuppressive therapy, patients with HIV infection who are severely immunocompromised)

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• Gently swirl the vial before withdrawing the dose; do not invert or shake the vial.
• Wait at least 1 minute after swirling the vial for complete reconstitution.
• Administer IM immediately after withdrawing the dose.

Storage requirements:

• Store between 2C to 8C (35F to 46F); store in the original package to protect from light.
• Do not freeze.

Reconstitution/preparation techniques:

• The manufacturer product information should be consulted.

Patient advice:

• Read the US FDA-approved patient labeling (Patient Information and Instructions for Use).

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer